Author

Horst Ruppach

Observed names: H Ruppach, H. Ruppach, HORST RUPPACH, Horst Ruppach, PhD

Observed institutions: Charles River Laboratories (Germany), Charles River Laboratories (United States), Georg Speyer Haus, Bayer (Germany)

OpenAlex ID: A5063727673

Serotyping of HIV Type 1 Infections: Definition, Relationship to Viral Genetic Subtypes, and Assay Evaluation

1998 · RACHANEE CHEINGSONG-POPOV, SALADIN OSMANOV, et al. · AIDS Research and Human Retroviruses · 100

Comparative Analysis of Dry and Wet Porometry Methods for Characterization of Regular and Cross-Linked Virus Removal Filter Papers

2018 · Simon Gustafsson, Frank Westermann, et al. · Membranes · 57

PDF

Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors.

1997 · U Dietrich, H Ruppach, et al. · PubMed · 50

Virus study for continuous low pH viral inactivation inside a coiled flow inverter

2018 · Laura David, Benjamin Maiser, et al. · Biotechnology and Bioengineering · 39

Human Immunodeficiency Virus (HIV)-Positive Sera Obtained Shortly after Seroconversion Neutralize Autologous HIV Type 1 Isolates on Primary Macrophages but Not on Lymphocytes

2000 · Horst Ruppach, Peter Nara, et al. · Journal of Virology · 33

Log10 Reduction Factors in Viral Clearance Studies

2014 · Horst Ruppach · BioProcessing Journal · 25

Molecular Epidemiology of HIV in Israel

1997 · Stephan Gehring, Shlomo Maayan, et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 24

Historical evaluation of the in vivo adventitious virus test and its potential for replacement with next generation sequencing (NGS)

2023 · Paul W. Barone, Flora J. Keumurian, et al. · Biologicals · 23

Use of a new RNA next generation sequencing approach for the specific detection of virus infection in cells

2019 · Audrey Brussel, Kerstin Brack, et al. · Biologicals · 23

PDF

Secondary Structural Elements as a Basis for Antibody Recognition in the Immunodominant Region of Human Immunodeficiency Viruses 1 and 2

1996 · Robert L. M. Markert, Horst Ruppach, et al. · European Journal of Biochemistry · 20

Indication for increasing prevalence of resistance mutations for protease inhibitors in therapy-naive HIV-1-positive German patients

1999 · Ursula Dietrich, Ina Raudonat, et al. · AIDS · 15

Selection of HIV-1 genotypes by cultivation in different primary cells

1999 · Hagen von Briesen, Manuel Grez, et al. · AIDS · 13

Twenty plus Years of Data Demonstrating Virus Filtration as an Effective and Robust Step for Large Virus Removal

2021 · Brad Stanley, Veronica Holmes, et al. · PDA Journal of Pharmaceutical Science and Technology · 9

Evaluation of a viral transcriptome Next Generation Sequencing assay as an alternative to animal assays for viral safety testing of cell substrates

2023 · Pascale Beurdeley-Fehlbaum, Matthew Pennington, et al. · Vaccine · 8

Risk of HIV transmission in infected US military personnel.

1996 · H Ruppach, H Knechten, et al. · PubMed · 7

Viral safety for biotherapeutics and biosimilar

2020 · Horst Ruppach · Drug Discovery Today Technologies · 6

PDF

Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses

2015 · P. De Vilmorin, A. Slocum, et al. · PDA Journal of Pharmaceutical Science and Technology · 6

Risk of HIV transmission in infected US military personnel

1996 · LydiaR. Temoshok, ThomasL. Patterson, et al. · The Lancet · 6

Multiple Presence and Heterogeneous Distribution of HIV-1 Subtypes in Nigeria

2001 · Georgina N. Odaibo, David O. Olaleye, et al. · 4

[Serotypes of the human immunodeficiency virus type 1 in Madrid].

1997 · V Soriano, U Dietrich, et al. · PubMed · 2

Circulating HIV‐1 Serotypes in Spain

1996 · V. Soriano, R. Andersen, et al. · Vox Sanguinis · 2

Mother to Child Transmission of Different HIV-1 Subtypes in Nigeria

2000 · David O. Olaleye, Georgina N. Odaibo, et al. · 1

Risk-based strategies for viral safety assurance

2025 · BioPhorum, Calvin Chan, et al.

Key topics in advanced therapy manufacturing: quality, safety, and supply

2021 · Jeffrey Hung, PhD, Professor Daniel C. Smith, et al. · Cell and Gene Therapy Insights

Characterization of Regular and Cross-linked Virus Removal Filter Papers: Comparative Analysis of Dry and Wet Porometry Methods and Virus Removal Properties

2018 · Simon Gustafsson, Frank Westermann, et al.

Works count: 25

Citation count: 473

H-index: 12

I10-index: 12